Emanuele Botteri studies the management of breast cancer, especially in early-stage patients who have small tumors (up to 2 cm). He investigates whether invasive procedures such as sentinel lymph node biopsy (a surgery to check for cancer spread) are necessary when imaging tests indicate no lymph node involvement. By comparing outcomes between patients who undergo surgery and those who do not, his work aims to spare patients from unnecessary procedures while maintaining effective cancer treatment.
Key findings
In the SOUND trial, after five years, 98% of patients experienced no distant cancer spread, with 97.7% in the sentinel lymph node biopsy group and 98.0% in the no surgery group.
The study demonstrates that avoiding axillary surgery does not lead to worse outcomes for patients with small breast cancer and negative lymph node imaging.
This approach allows patients to potentially avoid unnecessary surgery, reducing their surgical risk and recovery time.
Frequently asked questions
Does Dr. Botteri study breast cancer?
Yes, Dr. Botteri focuses on breast cancer, specifically early-stage cases with small tumors.
What treatments has Dr. Botteri researched?
He has researched the necessity of sentinel lymph node biopsy versus no surgery for patients with small breast cancer.
Is Dr. Botteri's work relevant to patients with small breast tumors?
Absolutely, his findings provide important insights for patients with small tumors and negative lymph node imaging by potentially avoiding unnecessary surgery.
Publications in plain English
Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment.
2026
International journal of cancer
Vandraas KF, Hjorth S, Trewin-Nybråten CB, Ursin G, Botteri E +5 more
Plain English This study looked at how patients with a specific type of metastatic breast cancer (HER2+) are treated with targeted therapies in real-life settings in Norway. Out of 715 patients analyzed, 28% did not receive any recommended anti-HER2 therapy, with older patients and those with more health issues being more likely to miss out on treatment. This is important because not receiving proper treatment can affect outcomes for patients with this aggressive cancer.
Who this helps: This helps patients with HER2+ metastatic breast cancer and their doctors.
Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently.
2026
Breast cancer research and treatment
Hjorth S, Vandraas KF, Trewin-Nybråten CB, Botteri E, Ursin G +2 more
Plain English This study looked at how older women with a specific type of breast cancer, called HER2-positive breast cancer, receive treatment in Norway. Researchers found that while 83-95% of women under 75 years old received anti-HER2 therapy, only 60% of those aged 75-79 and just 8% of women aged 90 and older were treated with these therapies. This is important because it shows that older patients may not be getting the effective treatment they need, highlighting the need for better guidelines for treating older women with this type of cancer.
Who this helps: This helps older women with HER2-positive breast cancer and their healthcare providers.
Use of claims data to identify adverse events after colonoscopy in a randomised colorectal cancer screening trial in Norway: a cross-sectional study.
2026
BMJ open
Rognstad ØB, Botteri E, Hoff G, Bretthauer M, Nguyen HD +3 more
Plain English This study examined whether claims data could effectively identify complications after colonoscopy during a colorectal cancer screening trial in Norway. The researchers found that out of 11,205 colonoscopies, there were 87 reported cases of lower gastrointestinal bleeding and 8 instances of perforation. However, the ability to detect bleeding varied by screening center—sensitivity rates for bleeding were 48.6% at one center and 36.0% at another, while perforation detection rates were lower, at 37.5% overall.
Who this helps: This research benefits healthcare providers and patients by improving the understanding of complications related to colonoscopy and highlighting the need for better reporting methods.
Effect of reminder phone calls in the language of origin on colorectal cancer screening participation among immigrants in Norway: a randomised controlled trial.
2026
The Lancet regional health. Europe
Iqbal N, Bhargava S, Hofvind S, Farah KS, Holme Ø +2 more
Plain English This study looked at how reminder phone calls in immigrants' native languages could boost participation in a colorectal cancer screening program in Norway. Researchers found that 24% of immigrants who received both a reminder letter in Norwegian and a phone call in their language completed the screening, compared to just 11% who received only the letter. This shows that using language-specific reminders can significantly increase participation in health screenings for immigrant communities.
Who this helps: This helps immigrants from countries like Pakistan and Somalia access important cancer screenings.
Performance of Faecal Immunochemical Testing for Colorectal Cancer Screening at Varying Positivity Thresholds.
2025
Alimentary pharmacology & therapeutics
Randel KR, Botteri E, de Lange T, Schult AL, Eskeland SL +6 more
Plain English This study looked at how different positivity levels for a stool test (FIT) used in colorectal cancer screening affect the number of colonoscopies performed, the cancer detected, and any complications arising from these procedures. In Norway, using a low threshold (15 µg/g) meant that 3,705 people had a colonoscopy and 203 were found to have cancer. In contrast, a higher threshold (150 µg/g) would have led to only 838 colonoscopies with fewer cancers detected—114 as opposed to 203—showing that while a higher threshold reduces the number of tests needed, it also leads to missing more cases of cancer and more serious lesions.
Who this helps: This research benefits patients by helping healthcare providers choose the best screening options to detect colorectal cancer early.
Plain English This study looked at the impact of beta-blockers, commonly used for heart issues, on the survival of women with epithelial ovarian cancer (EOC) in Norway. Researchers found that women who used beta-blockers around the time of their cancer diagnosis lived an average of 1.28 months longer than those who didn't, suggesting these medications may improve survival specifically related to EOC. This matters because it highlights a potential way to enhance the treatment outcomes for women battling this type of cancer.
Who this helps: Patients with epithelial ovarian cancer.
Non-steroidal anti-inflammatory medication use and endometrial cancer survival: A population-based Norwegian cohort study.
2025
International journal of cancer
Haug AJ, Støer N, Langseth H, Siafarikas F, Botteri E +2 more
Plain English This study looked at how using anti-inflammatory medications, specifically aspirin and other non-aspirin NSAIDs, affects survival rates in patients with endometrial cancer (EC) in Norway. Researchers found that among nearly 8,000 patients, those taking aspirin had a 19% higher risk of dying from any cause, and those using non-aspirin NSAIDs faced a 25% increased risk of dying from cancer. These findings highlight a potential danger in using these common medications after being diagnosed with endometrial cancer.
Who this helps: This helps patients with endometrial cancer and their doctors make informed decisions about medication use.
Beta blocker use and breast cancer survival by subtypes: A population-based cohort study.
2025
Breast (Edinburgh, Scotland)
Scott OW, Tin Tin S, Botteri E
Plain English This research studied the effects of beta blockers, a type of medication, on the survival of women with breast cancer in New Zealand. Out of over 13,000 women, those using beta blockers did not show a significant overall survival benefit compared to non-users, but those with triple negative breast cancer experienced a longer time without disease recurrence and a potentially lower risk of dying from breast cancer. Specifically, women with triple negative breast cancer had a 29% longer time without recurrence when using beta blockers.
Who this helps: This helps women with triple negative breast cancer and their doctors.
Differences in colonoscopy performance among four endoscopy centers in Western Norway: Influence of case-mix.
2025
Endoscopy international open
Pedersen TA, Engjom T, Dimcevski GG, Botteri E, Seip B +1 more
Plain English This study looked at how patient characteristics, like age and sex, affected the quality of colonoscopy procedures at four hospitals in Western Norway. They found that older patients and men had higher rates of polyp detection, while certain health issues, like inflammatory bowel disease, led to lower detection rates. Overall, the study showed that where a person gets their colonoscopy can affect the outcomes, highlighting the need to consider patient differences when evaluating these procedures.
Who this helps: This research helps doctors and patients by identifying factors that affect colonoscopy effectiveness.
Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway.
2025
BMC cancer
Støer NC, Botteri E, Lindemann K, Langseth H, Fortner RT
Plain English This study looked at how using low-dose aspirin and other non-steroidal anti-inflammatory drugs (NA-NSAIDs) affects survival in women diagnosed with epithelial ovarian cancer (EOC) from 2004 to 2018. It found that while taking low-dose aspirin after diagnosis seemed to help women live longer—with an increase of about 2.67 months compared to those who never used it—the overall effect of NA-NSAIDs was less clear. These results matter because they suggest that low-dose aspirin may improve survival outcomes for women with EOC.
Who this helps: This helps patients with epithelial ovarian cancer.
[F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial.
2025
European journal of cancer (Oxford, England : 1990)
Di Micco R, Botteri E, Canevari C, Gallivanone F, Antunovic L +24 more
Plain English This study looked at a new imaging technique, [F]FDG PET/MRI, to see how well it can detect cancer spread to lymph nodes in early breast cancer patients. Out of 246 women treated, it correctly identified cancer in 43 out of 61 cases of lymph node spread, which is about 70.5%. This method was more accurate than traditional imaging methods alone, potentially reducing the need for surgery in some patients.
Who this helps: This helps breast cancer patients by offering a less invasive way to check for cancer spread.
Correction: Quality of life among women with symptomatic, screen‑detected, and interval breast cancer, and for women without breast cancer: a retrospective cross‑sectional study from Norway.
2025
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Moshina N, Falk RS, Botteri E, Larsen M, Akslen LA +2 more
Aprepitant use during chemotherapy and association with survival in women with early breast cancer.
2025
Journal of the National Cancer Institute
Botteri E, Hjorth S, Conforti F, Bagnardi V, Andreassen BK +6 more
Plain English This study looked at how the drug aprepitant, used to prevent nausea during chemotherapy, impacts survival for women with early breast cancer. Researchers followed nearly 14,000 women and found that those who took aprepitant had improved survival rates, specifically women with non-luminal breast cancer (with a 34% better chance of surviving without disease spread) and triple-negative breast cancer (with a 39% better chance of survival). These findings are important because they suggest that aprepitant not only helps manage side effects of chemotherapy but may also improve cancer outcomes for certain patient groups.
Who this helps: This benefits women with early non-luminal breast cancer, especially those with triple-negative breast cancer.
Statins and the risk of gynecological cancer: a Norwegian population-based cohort study.
2025
International journal of epidemiology
Löfling LL, Støer NC, Botteri E, Fortner RT
Plain English This study looked at the use of statins—common medications for heart conditions—and their link to gynecological cancers like endometrial, ovarian, and cervical cancer among women aged 50 and older in Norway. Researchers followed over 1 million women for about 11.6 years and found that those currently using statins had a 10% lower risk of endometrial cancer, while past users had a 21% lower risk, but no similar benefits were found for ovarian or cervical cancers. Understanding this connection could help inform treatment decisions for women at risk of endometrial cancer.
Who this helps: This helps women at risk of endometrial cancer and their healthcare providers.
Lifestyle Change After Initial Colonoscopy Screening and Incidence of Colorectal Cancer and Major Chronic Diseases.
2025
The American journal of gastroenterology
Knudsen MD, Wang K, Wang L, Polychronidis G, Berstad P +5 more
Plain English This study explored how changes in lifestyle after a first colonoscopy screening affect the risk of colorectal cancer (CRC) and other serious chronic diseases. Researchers looked at data from over 118,000 people and found that those who improved their healthy lifestyle score by just one point had a 14% lower chance of developing CRC and an 11% lower chance of major chronic diseases over about 10 years. This is important because lifestyle changes, like exercising more and quitting smoking, can significantly lower the risk of serious health issues after screening.
Who this helps: This benefits patients by encouraging them to adopt healthier habits after screening.
Long-term quality of life and quality adjusted life years after breast cancer: Impact of detection mode, tumor characteristics and treatment.
2025
Journal of cancer policy
Moshina N, Falk RS, Botteri E, Larsen M, Akslen LA +3 more
Plain English This study looked at how women's quality of life after breast cancer differs based on whether they were diagnosed through screening or because they had symptoms. The research found that women diagnosed by screening reported a quality of life score of 66.2, while those diagnosed due to symptoms had a score of 62.5. Additionally, women diagnosed through screening gained an average of 2.30 quality-adjusted life years (QALYs), compared to 2.06 for those diagnosed due to symptoms, showing that earlier detection leads to better long-term outcomes.
Who this helps: This information benefits breast cancer patients and healthcare providers by highlighting the advantages of regular screening.
Lifestyle changes and postmenopausal breast cancer risk in women from the European Prospective Investigation into Cancer and Nutrition.
2025
Breast cancer research : BCR
Vasson F, Matta K, Biessy C, S Antoniussen C, Fournier A +23 more
Plain English This study looked at how changes in lifestyle, measured by a Healthy Lifestyle Index (HLI), affect the risk of breast cancer in postmenopausal women. Out of 125,746 women, 2,175 developed breast cancer during an average follow-up of nearly 4 years. The findings showed that while overall lifestyle changes didn’t reduce breast cancer risk, improving body weight (reflected by BMI) was associated with a lower risk of developing breast cancer, particularly among those with estrogen receptor-positive tumors.
Who this helps: This research benefits women, particularly those who are postmenopausal and seeking to understand how lifestyle choices may affect their breast cancer risk.
Preliminary Cost-Effectiveness of Re-Purposing β-Blockers as an Adjunct Treatment for Women with Triple-Negative Breast Cancer.
2025
Healthcare (Basel, Switzerland)
Lloyd M, Sloan EK, Marquina C, Bouttell J, Hassanien O +2 more
Plain English This study looked at whether adding β-blockers to the usual treatment for women with triple-negative breast cancer (TNBC) is more effective and less expensive than standard care alone. The researchers found that women taking β-blockers gained an average of 628 years of life lived, 526 quality-adjusted life years, and saved about AUD 935,116 in healthcare costs compared to those receiving only standard care. This research matters because it suggests that β-blockers could improve patient outcomes while also being cost-effective.
Who this helps: This helps women diagnosed with triple-negative breast cancer and their doctors.
Colonic Resection, Stoma, or Self-expanding Metal Stents for Obstructive Left Colon Cancer: the CROSCO-1 study protocol.
2024
Minerva surgery
Giordano A, Podda M, Montori G, Botteri E, Fugazzola P +18 more
Plain English The CROSCO-1 study looked at different treatment options for patients with left colon cancer that causes bowel blockage. It specifically compared emergency surgeries, like removing part of the colon, to using temporary stents to relieve the blockage. The goal is to determine which method results in fewer patients needing a permanent stoma after one year.
Who this helps: This research benefits patients with obstructive left colon cancer and their doctors by guiding treatment decisions.
Diverticulitis, surgery, evidence-based medicine, and the Steve Jobs' dots: a narrative review.
2024
European journal of trauma and emergency surgery : official publication of the European Trauma Society
Agresta F, Montori G, Podda M, Ortenzi M, Giordano A +21 more
Plain English This research paper reviews how acute diverticulitis is treated, looking at studies from the past 60 years to gather insights. It highlights the significance of factors like laparoscopic surgery, the acute care environment, and the qualifications of surgeons, emphasizing that a comprehensive approach is necessary for effective treatment. The authors advocate for integrating evidence-based practices with a surgeon's expertise to improve patient outcomes in diverticulitis management.
Who this helps: This helps patients suffering from diverticulitis and healthcare providers involved in their care.
Safety of laparoscopic cholecystectomy performed by trainee surgeons with different cholangiographic techniques (SCOTCH): a prospective non-randomized trial on the impact of fluorescent cholangiography during laparoscopic cholecystectomy performed by trainees.
2024
Surgical endoscopy
Ortenzi M, Corallino D, Botteri E, Balla A, Arezzo A +7 more
Plain English This study looked at how different imaging techniques help trainee surgeons during gallbladder removal surgery, specifically laparoscopic cholecystectomy. Researchers found that using near-infrared fluorescent cholangiography (NIRF-C) improved the ability to see important bile ducts, leading to better surgical satisfaction, but did not affect the time taken for the surgery. In total, 338 patients were involved, and injuries to bile ducts occurred in 3 cases, with 2 in the traditional lighting method and 1 in the NIRF-C group.
Who this helps: This research benefits both trainee surgeons and patients undergoing gallbladder surgery.
Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition.
2024
European journal of epidemiology
Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G +39 more
Plain English This study looked at how changing lifestyle habits in middle-aged people affects the risk of developing cancer. Researchers tracked nearly 300,000 participants over several years and found that for each point increase in a healthy lifestyle score, there was a 4% lower risk of lifestyle-related cancers. Participants who improved their lifestyles significantly reduced their cancer risk, while those who worsened theirs had a higher risk.
Who this helps: This helps middle-aged individuals looking to lower their cancer risk through healthier choices.
Correction: Safety of laparoscopic cholecystectomy performed by trainee surgeons with different cholangiographic techniques (SCOTCH): a prospective non-randomized trial on the impact of fluorescent cholangiography during laparoscopic cholecystectomy performed by trainees.
2024
Surgical endoscopy
Ortenzi M, Corallino D, Botteri E, Balla A, Arezzo A +7 more
Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway.
2024
The American journal of gastroenterology
Nafisi S, Støer NC, Veierød MB, Randel KR, Hoff G +3 more
Plain English This study investigated whether taking low-dose aspirin reduces the risk of colorectal cancer (CRC) among people aged 50 and older in Norway between 2004 and 2018. They found that people currently using low-dose aspirin had a 13% lower risk of developing CRC compared to those who never used it, and those who had used it for 5 years or more showed an even lower risk. Overall, it was estimated that the use of aspirin may have prevented over 1,000 cases of CRC during the study period, showing that aspirin could play an important role in cancer prevention.
Who this helps: This helps patients who are at risk for colorectal cancer and their doctors in making informed decisions about preventive care.
Rectus muscle diastasis in Italian women: determinants of disease severity, and associated disorders.
2024
Frontiers in surgery
Sartori A, Tfaily A, Botteri E, Andreuccetti J, Lauro E +3 more
Plain English This study explored the separation of abdominal muscles, known as diastasis recti, in Italian women, particularly during and after pregnancy. It found that the severity of this condition increases with higher body weight and more pregnancies; for example, 22.8% of women with normal weight had a separation greater than 5 cm, compared to 44.0% in severely obese women. Additionally, women with more severe separations faced increased risks of related issues like abdominal hernias and urinary incontinence.
Who this helps: This information helps women experiencing postpartum issues and healthcare professionals treating them.
Towards a tailored approach for patients with acute diverticulitis and abscess formation. The DivAbsc2023 multicentre case-control study.
2024
Surgical endoscopy
Podda M, Ceresoli M, Di Martino M, Ortenzi M, Pellino G +31 more
Plain English This study looked at patients with diverticulitis who had abscesses and were treated without surgery to see why some treatments didn't work. Out of 428 patients, about 27% (116 patients) needed emergency surgery because the treatment failed. Factors like having a more serious type of abscess, being a smoker, and air inside the abscess made it more likely for treatment to fail, especially in younger smokers with larger abscesses.
Who this helps: This helps doctors determine which patients might need closer monitoring or different treatment options for diverticulitis.
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.
2024
British journal of cancer
Støer NC, Vangen S, Singh D, Fortner RT, Hofvind S +2 more
Plain English Researchers studied the relationship between menopausal hormone therapy (HT) and breast cancer risk in over 1.3 million women in Norway over an average of nearly 13 years. They found that women using oral estrogen combined with progestin had the highest risk of breast cancer, more than double that of non-users (risk ratio of 2.42). Importantly, vaginal estrogen wasn’t linked to any increased breast cancer risk, and higher body mass index (BMI) was associated with lower risks from HT.
Who this helps: This information benefits women considering menopausal hormone therapy and their doctors.
Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort.
2024
BMC medicine
Matta K, Viallon V, Botteri E, Peveri G, Dahm C +35 more
Plain English This study looked at how changes in lifestyle habits impact overall death rates and cancer deaths among nearly 308,500 adults in Europe over approximately 10 years. It found that people who improved their healthy lifestyle habits reduced their risk of death by 16% and their risk of dying from cancer by 13%. On the other hand, those who made their lifestyle habits worse increased their risk of death by 26% overall and 19% from cancer.
Who this helps: This benefits patients by highlighting the importance of maintaining or improving healthy lifestyle choices for better longevity.
Impact of inadequate bowel cleansing in sigmoidoscopy screening.
2024
Scandinavian journal of gastroenterology
Randel KR, Schult AL, Botteri E, Nawaz M, Nguyen DH +4 more
Plain English This study looked at how well patients are prepared for sigmoidoscopy screenings, which help detect colorectal cancer. Researchers found that only 58.6% of the 35,710 participants had excellent bowel cleaning, and those with poor cleaning had a lower chance of adenomas being found—13% compared to 17% for those with excellent cleaning. This matters because inadequate preparation can make screenings less effective, meaning cancers could be missed.
Who this helps: Patients undergoing sigmoidoscopy screenings.
Systematic review and meta-analysis of the use of high-energy devices for thyroid surgery.
2024
Langenbeck's archives of surgery
Montori G, Botteri E, Ortenzi M, Gerardi C, Allocati E +7 more
Plain English This research reviewed studies comparing high-energy devices (HEDs) to traditional methods for thyroid surgery. The findings showed that using HEDs led to shorter surgery times (about 128.8 minutes less), reduced blood loss during surgery, shorter hospital stays, and lower costs. This matters because it suggests that HEDs can make thyroid surgeries safer and more efficient.
Who this helps: Patients undergoing thyroid surgery.
Adverse events after colonoscopy in a randomised colorectal cancer screening trial.
2024
BMJ open gastroenterology
Rognstad ØB, Botteri E, Hoff G, Bretthauer M, Gulichsen E +3 more
Plain English This study looked at complications that can occur after colonoscopy procedures as part of colorectal cancer screening in Norway. Out of over 10,000 people who had a colonoscopy, about 242 (or 2.4%) experienced some type of adverse event related to the procedure, with most being mild; for instance, 188 people had minor issues like abdominal pain, while only one person had a fatal event. Understanding these risks, especially for certain groups like older women or those on blood thinners, can help doctors keep patients safer during these screenings.
Who this helps: Patients undergoing colonoscopy screening.
Botti M, Jongen ACHM, Bîrlog C, Botteri E, Boshier PR +3 more
Plain English This study examined the educational needs of young surgeons in Europe, focusing on those under 40 years old. Out of 386 surgical residents surveyed, 56% emphasized the importance of scientific research for their professional growth, although many found it challenging to access necessary resources. The findings will help shape future educational programs and support for young surgeons, which is crucial for their development and success in their careers.
Who this helps: This benefits young surgeons and surgical residents who are seeking better training and networking opportunities.
Feeding Method, Nicotine Exposure, and Growth during Infancy.
2024
Journal of pediatrics. Clinical practice
Shenassa ED, Botteri E, Stensheim H
Plain English This study looked at how breastfeeding from smokers affects infant growth, focusing on whether smokers' breastmilk leads to rapid weight and length gain. Researchers found that babies breastfed by heavy smokers gained an average of 100 grams and 2.8 mm in length, indicating that exposure to nicotine through breastmilk may influence their growth. This is important because it highlights the risks associated with breastfeeding while smoking, which could impact infant health.
Who this helps: This helps parents, particularly those who smoke, by showing the risks of nicotine exposure through breastmilk.
Nationwide analysis of inpatient laparoscopic ventral hernia repair in Italy from 2015 to 2020.
2023
Updates in surgery
Botteri E, Ortenzi M, Williams S, Balla A, Podda M +2 more
Plain English This study looked at how often laparoscopic surgery (a minimally invasive technique) was used to repair ventral hernias in Italy from 2015 to 2020. Out of over 154,000 hernia repairs during that time, about 20,800 (or 13.45%) were done using the laparoscopic method, with its use increasing from 11.96% in 2015 to 15.24% in 2020. The findings are significant as they provide a clear picture of how surgical practices are evolving in Italy and highlight a growing trend toward less invasive procedures, which can lead to quicker recovery times for patients.
Who this helps: This benefits patients undergoing hernia surgery by providing safer and less invasive treatment options.
Overall lifestyle changes in adulthood are associated with cancer incidence in the Norwegian Women and Cancer Study (NOWAC) - a prospective cohort study.
2023
BMC public health
Chen SLF, Nøst TH, Botteri E, Ferrari P, Braaten T +2 more
Plain English This study examined how changes in lifestyle among adult women affected the risk of developing cancer. Researchers found that women who improved their lifestyles saw a decrease in cancer rates; specifically, positive lifestyle changes were linked to a lower incidence of lifestyle-related cancers, while worsening lifestyles were associated with a higher risk. For example, women who made significant improvements in their health habits had a notably lower risk of developing certain cancers.
Who this helps: This information benefits women looking to reduce their cancer risk through healthier choices.
Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study.
2023
Lung cancer (Amsterdam, Netherlands)
Sanjinez C, Botteri E, Støer NC, Lukas Löfling L
Plain English This study looked at whether using antimuscarinics, a type of medication, affects survival rates for people with lung cancer in Norway. Researchers followed over 26,000 lung cancer patients and found that those who started taking antimuscarinics after their cancer diagnosis had a lower risk of dying from the disease—specifically, a 16% improved survival rate compared to those who didn’t use these medications. This is important because it suggests that antimuscarinics might help some lung cancer patients live longer.
Who this helps: Patients with lung cancer and their doctors.
Use of High Energy Devices (HEDs) versus electrocautery for laparoscopic cholecystectomy: a systematic review and meta-analysis of randomised controlled trials.
2023
Surgical endoscopy
Ortenzi M, Agresta F, Vettoretto N, Gerardi C, Allocati E +8 more
Plain English The study looked at the effectiveness and safety of High Energy Devices (HEDs) compared to standard electrocautery tools during laparoscopic gallbladder surgery. It found that surgeries using HEDs were completed about 24 minutes faster on average than those using electrocautery, with no increase in complications or safety concerns. This is important because faster surgeries can improve patient turnover and reduce healthcare costs.
Who this helps: This benefits both patients, by potentially reducing surgery time, and doctors, by streamlining their work.
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer.
2023
Science translational medicine
Chang A, Botteri E, Gillis RD, Löfling L, Le CP +20 more
Plain English This study looked at how beta-blockers, which are typically used to manage high blood pressure, can improve the effectiveness of a chemotherapy drug called doxorubicin in treating triple-negative breast cancer (TNBC). It found that using beta-blockers alongside doxorubicin reduced the spread of cancer in lab models, with a significant increase in the drug's effectiveness. This matters because it suggests that combining these treatments may help prevent disease recurrence and improve survival rates for patients with TNBC.
Who this helps: This benefits patients with triple-negative breast cancer.
Minimally invasive versus open adrenalectomy for adrenocortical carcinoma: the keys surgical factors influencing the outcomes-a collective overview.
2023
Langenbeck's archives of surgery
Giordano A, Feroci F, Podda M, Botteri E, Ortenzi M +5 more
Plain English This study looked at two types of surgery for treating adrenocortical carcinoma (A.C.C.), a rare and aggressive cancer. Researchers reviewed data from 18 studies involving 14,600 patients and found that while minimally invasive surgery (M.I.S.) led to shorter hospital stays, it had higher recurrence rates (26-36%) compared to open surgery (24-29%). Overall, open surgery is still favored because it generally offers better outcomes in terms of surgery success and fewer complications.
Who this helps: This information helps doctors decide the best surgical options for patients with adrenocortical carcinoma.
Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer.
2023
Frontiers in pharmacology
Tan GSQ, Botteri E, Wood S, Sloan EK, Ilomäki J
Plain English This study looked at whether commonly prescribed beta-blockers could help reduce breast cancer deaths in women over 50. Researchers examined data from 2,758 women, of which 604 took beta-blockers and 1,387 took other blood pressure medications. They found no strong evidence that beta-blockers improved survival rates for breast cancer, although there was a hint of potential benefit for women with triple-negative breast cancer, which needs further investigation.
Who this helps: This research helps oncologists and researchers looking for new treatment options for breast cancer patients.
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
2023
Breast cancer research : BCR
Löfling LL, Støer NC, Andreassen BK, Ursin G, Botteri E
Plain English This study looked at whether taking low-dose aspirin, statins, or metformin after being diagnosed with breast cancer affects how long patients survive. The research involved over 26,000 women, and it found that those who used statins had a 16% lower risk of dying from breast cancer, while those on metformin had a 30% lower risk compared to non-users. This matters because it suggests that these common medications might help improve survival rates for breast cancer patients.
Who this helps: This helps breast cancer patients.
Lower participation among immigrants in colorectal cancer screening in Norway.
2023
Frontiers in public health
Bhargava S, Botteri E, Berthelsen M, Iqbal N, Randel KR +2 more
Plain English This study looked at how different immigrant groups in Norway participate in colorectal cancer screening, specifically comparing them to non-immigrants. Out of 106,695 non-immigrants, 60% participated in a stool test for screening, while only 37% of immigrants from non-Western countries did the same. This is important because lower participation rates in screening could lead to more late-stage cancer diagnoses among these groups, putting their health at greater risk.
Who this helps: This helps patients, especially immigrants from non-Western countries, by highlighting the need for better outreach and support in cancer screening programs.
Nationwide analysis of open groin hernia repairs in Italy from 2015 to 2020.
2023
Hernia : the journal of hernias and abdominal wall surgery
Ortenzi M, Botteri E, Balla A, Podda M, Montori G +1 more
Plain English This study looked at how inguinal hernia surgeries were done in Italy from 2015 to 2020. Researchers found that the number of these surgeries dropped significantly from 122,737 in 2015 to 65,780 in 2020, with elective surgeries becoming more common than urgent ones, decreasing overall by about 18.74% during the study period. This matters because understanding these trends helps improve surgical practices and patient care, especially as more patients are opting for less invasive methods like laparoscopy.
Who this helps: This benefits patients needing hernia repairs and their doctors.
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
2023
JAMA oncology
Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M +26 more
Plain English This study examined whether skipping axillary surgery is as effective as performing a sentinel lymph node biopsy (SLNB) for women with small breast cancer (up to 2 cm) and negative lymph node imaging. The research found that after five years, about 98% of patients in both groups were free from distant cancer spread—97.7% for the SLNB group and 98.0% for the no surgery group—showing that not doing the surgery did not worsen outcomes. This is important because it means patients may avoid unnecessary surgery without increasing their risk of cancer recurrence.
Who this helps: This benefits patients with small breast cancer who have negative lymph node imaging, allowing them to avoid additional surgery if it's not necessary.